- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/33 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Clostridium (G)
Patent holdings for IPC class C07K 14/33
Total number of patents in this class: 782
10-year publication summary
|
59
|
51
|
61
|
70
|
69
|
71
|
58
|
54
|
46
|
10
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2372 |
56 |
| MERZ PHARMA GmbH & CO. KGaA | 617 |
38 |
| Ipsen Biopharm Limited | 264 |
34 |
| President and Fellows of Harvard College | 5905 |
26 |
| Ipsen Bioinnovation Limited | 45 |
23 |
| Glaxosmithkline Biologicals S.A. | 1628 |
22 |
| Children's Medical Center Corporation | 1830 |
22 |
| Wisconsin Alumni Research Foundation | 3858 |
18 |
| The Regents of the University of California | 19681 |
15 |
| Wyeth LLC | 653 |
13 |
| Pfizer Inc. | 3331 |
12 |
| Revance Therapeutics, Inc. | 150 |
12 |
| Daewoong Co., Ltd. | 63 |
11 |
| Valneva Austria GmbH | 114 |
11 |
| Massachusetts Institute of Technology | 9942 |
10 |
| The Governors of the University of Alberta | 869 |
7 |
| Osaka University | 3329 |
7 |
| Vaxiion Therapeutics, LLC | 20 |
7 |
| New York University | 1717 |
6 |
| University of Guelph | 350 |
6 |
| Other owners | 426 |